Clin Infect Dis Off Publ Infect Dis Soc America (2016) 63(9):11519
76,81,96,97 The main factor contributing to the lack of greater investment in lixisenatide and other short-acting agents for MASLD may be their influence on metabolic function, including pharmacokinetic differences induced by a single-dose method and their effects on gastric emptying, 91 which could limit their effectiveness in improving glycolipid metabolism
FIGURE 3 FIGURE 4 Causal effect of six cancers on endogenous antioxidants Based on the Bonferroni-corrected threshold, no significant causal association between the six cancers and endogenous antioxidants was found in the reverse MR analysis (Figure 3B)
One of the gallbladder-related risks associated with GLP-1 weight-loss medications, gallstone formation, is no longer relevant once the gallbladder has been removed
At the end of the treatment phase, researchers measured changes in knee pain, function, and body weight